Skip to main content
Log in

Magnesium deficiency in adult rats promotes the induction of ventricular tachycardia by the administration of epinephrine

  • Originals
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Summary

The effects of magnesium deficiency on epinephrine-induced ventricular tachyarrhythmia were investigated in adult rats. Forty-two adult Wistar rats were fed a magnesium-deficient diet while 30 rats were fed a standard diet for 20 days. The plasma magnesium concentration was lower in the magnesium-deficient rats (0.22 ± 0.01mmol/l) than in the control rats (0.76 ± 0.03 mmol/l,P < 0.001). Using a telemetry system, electrocardiograms and arterial blood pressure were recorded on a polygraph in an unrestrained condition. Epinephrine was infused intravenously starting at 5 µg/kg per minute. The QT interval was prolonged to 50 ± 1ms in the magnesium-deficient rats compared with 44 ± 1 ms in the control rats (P < 0.001). Before the administration of epinephrine, no ventricular tachyarrhythmias or seizures were found in either the control or the magnesium-deficient rats. The incidence of epinephrine-induced sustained ventricular tachycardia (VT) was higher in the magnesiumdeficient rats (86%) than in the control rats (43%,P < 0.01). However, this VT did not result in sudden death. Seizures always preceded death in both the magnesium-deficient and control rats while the arrhythmias observed immediately before death were mainly bradyarrhythmias. The present study in an adult rat magnesium-deficient model revealed that magnesium deficiency enhances the susceptibility to epinephrine-induced ventricular tachyarrhythmias.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Eisenberg MJ (1992) Magnesium deficiency and sudden death. Am Heart J 124:544–549

    PubMed  Google Scholar 

  2. Surawicz B (1989) Is hypomagesemia or magnesium deficiency arrhythmogenic? J Am Coll Cardiol 14:1093–1096

    PubMed  Google Scholar 

  3. Millane TA, Ward DE, Camm AJ (1992) Electrophysiology, pacing, and arrhythmia. Is hypomagnesemia arrhythmogenic? Clin Cardiol 15:103–108

    PubMed  Google Scholar 

  4. Iseri LT, Freed J, Bures AR (1975) Magnesium deficiency and cardiac disorders. Am J Med 58:837–846

    PubMed  Google Scholar 

  5. Eisenberg MJ (1986) Magnesium deficiency and cardiac arrhythmias. NY State J Med 86:133–136

    Google Scholar 

  6. Topol EJ, Lerman BB (1983) Hypomagnesemic torsades de pointes. Am J Cardiol 52:1367–1368

    PubMed  Google Scholar 

  7. Loeb HS, Pietras RJ, Gunnar RM, Tobin JR (1968) Paroxysmal ventricular fibrillation in two patients with hypomagnesemia — treatment by transvenous pacing. Circulation 37:210–215

    Google Scholar 

  8. Keller PK, Aronson RS (1990) The role of magnesium in cardiac arrhythmias. Prog Cardiovasc Dis 32:433–448

    PubMed  Google Scholar 

  9. Keren A, Tzivoni D (1990) Magnesium therapy in ventricular arrhythmias. PACE 13:937–945

    PubMed  Google Scholar 

  10. Goto Y, Nakamura M, Abe S, Kato M, Fukui M (1993) Physiological correlates of abnormal behaviors in magnesium-deficient rats. Epilepsy Res 15:81–89

    PubMed  Google Scholar 

  11. Nakamura M, Abe S, Goto Y, Chishaki A, Akazawa K, Kato M (1994) In vivo assessment of prevention of whitenoise-induced seizure in magnesium-deficient rats by N-methyl-d-aspartate receptor blockers. Epilepsy Res 17:249–256

    PubMed  Google Scholar 

  12. Nakamura M, Abe S, Goto Y, Chishaki A (1995) Sudden sound-induced death in magnesium-deficient rats after repetitive episodes of seizures result from brain dysfunction. Magnes Res 8:47–53

    PubMed  Google Scholar 

  13. Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939–1951

    PubMed  Google Scholar 

  14. Kawasaki H, Watanabe S, Ueki S (1979) Effects of psychotropic drugs on pressor and behavioral responses to brain stimulation in unrestrained, unanesthetized rats. Pharmacol Biochem Behav 10:907–915

    PubMed  Google Scholar 

  15. Rabkin SW (1993) Morphine and morphiceptin increase the threshold for epinephrine-induced cardiac arrhythmias in the rat through brain mu opioid receptors. Clin Exp Pharmacol Physiol 20:95–102

    PubMed  Google Scholar 

  16. Rabkin SW (1991) Angiotensin in the brain suppresses epinephrine-induced cardiac arrhythmias through CNS opioid mechanisms. Life Sci 49:1183–1190

    PubMed  Google Scholar 

  17. Bazett HC (1920) An analysis of the time-relations of electrocardiograms. Heart 7:353–370

    Google Scholar 

  18. Benedetti J, Yuen K, Young L (1990) Life Tables and survivor function 1L. In: Dixon WJ (ed) BMDP statistical software manual. University of California Press, Berkeley; pp 739–768

    Google Scholar 

  19. Kainuma M, Suzuki A (1986) Convulsions after adrenaline administration during enflurane anaesthesia. Anaesthesia 41:874–875

    PubMed  Google Scholar 

  20. Bean JW, Johnson P, Smith CW (1954) Adrenocortical and medullary factors in O2 at high pressure. Fed Proc 13:9

    Google Scholar 

  21. Hof DG, Cline WH Jr, Dexter JD, Mengel CE (1972) CNS epinephrine tone, a possible etiology for the threshold in susceptibility to oxygen toxicity seizures. Aerosp Med 43:1194–1199

    PubMed  Google Scholar 

  22. Watanabe Y, Dreifus LS (1972) Electrophysiological effects of magnesium and its interactions with potassium. Cardiovasc Res 6:79–88

    PubMed  Google Scholar 

  23. Guideri G, Lehr D, Horowitz S (1985) Enhanced incidence of isoproterenol induced ventricular fibrillation in the magnesium-deficient rat. J Am Coll Nutr 4:139–155

    Google Scholar 

  24. Hattori E, Yatsuki K, Miyazaki T, Sata T, Nakamura M (1969) Adenine nucleotides of myocardium from rats treated with isoproterenol and/or Mg- or K-deficiency. Jap Heart J 3:218–224

    Google Scholar 

  25. Fiset C, Kargacin ME, Kondo CS, Lester WM, Duff HJ (1996) Hypomagesemia: characterization of a model of sudden cardiac death. J Am Coll Cardiol 27:1771–1776

    PubMed  Google Scholar 

  26. Wexler BC, Kittinger GW (1963) Myocardial necrosis in rats: serum enzymes, adrenal steroid and histopathological alterations. Circ Res 13:159–171

    Google Scholar 

  27. Vormann J, Fisher G, Classen HG, Thöni H (1983) Influence of decreased and increased magnesium supply on the cardiotoxic effects of epinephrine in rats. Drug Res 33:205–210

    Google Scholar 

  28. Arsenian MA (1993) Magnesium and cardiovascular disease. Prog Cardiovasc Dis 35:271–310

    PubMed  Google Scholar 

  29. Burch GE, Giles TD (1977) The importance of magnesium deficiency in cardiovascular disease. Am Heart J 94:649–657

    PubMed  Google Scholar 

  30. Vitale JJ, Hellerstein EE, Nakamura M, Lown B (1961) Effects of magnesium-deficient diet upon puppies. Circ Res 9:387–394

    PubMed  Google Scholar 

  31. Skou JC, Butler KW, Hansen O (1971) The effect of magnesium, ATP, Pi, and sodium on the inhibition of the (Na+-K+)-activated enzyme system, by g-strophanthin. Biochim Biophys Acta 241:443–461

    PubMed  Google Scholar 

  32. Iseri LT, French JH (1984) Magnesium: nature's physiologic calcium blocker. Am Heart J 108:188–193

    PubMed  Google Scholar 

  33. Shine KI (1979) Myocardial effects of magnesium. Am J Physiol 237:H413–423

    PubMed  Google Scholar 

  34. Agus ZS, Kelepouris E, Dukes I, Morad M (1989) Cytosolic magnesium modulates calcium channel activity in mammalian ventricular cells. Am J Physiol 256:C452–455

    PubMed  Google Scholar 

  35. Quamme GA, Rabkin SW (1990) Cytosolic free magnesium in cardiac myocytes: identification of a Mg2- influx pathway. Biochem Biophys Res Commun 167:1406–1412

    PubMed  Google Scholar 

  36. Sakaguchi H, Sakaguchi R, Ishiguro S, Nishio A (1992) Beneficial effects of a calcium antagonist, nifedipine, on death and cardiovascular calcinosis induced by dietary magnesium deficiency in adult mice. Magnes Res 5:121–125

    PubMed  Google Scholar 

  37. Bajusz von E (1964) Electrolyte-shift in the myocardium — its significance for pathogenesis and prevention of necrotizing cardiac lesions. Drug Res 14:1115–1128

    Google Scholar 

  38. Edston E (1997) Evaluation of agonal artifacts in the myocardium using a combination of histological stains and immunohistochemistry. Am J Forens Med Pathol 18:163–167

    Google Scholar 

  39. Lie JT, Holley KE, Kampa WR, Titus JL (1971) New histochemical method for morphologic diagnosis of early stages of myocardial ischemia. Mayo Clin Proc 46:319–327

    PubMed  Google Scholar 

  40. Fu C, Song Y, Zhu J (1993) Immunocytochemical study with anti-muscle actin antibody (HHF35) on myocardial ischaemia and reperfusion injury in rats. Forens Sci Int 59:25–34

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was supported in part by grants from the Salt Science Research Foundation (9131, 92045)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tomiyasu, T., Chishaki, A. & Nakamura, M. Magnesium deficiency in adult rats promotes the induction of ventricular tachycardia by the administration of epinephrine. Heart Vessels 13, 122–131 (1998). https://doi.org/10.1007/BF01747829

Download citation

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01747829

Key words

Navigation